elexacaftorCFTRmivacaftortezacaftorcystic fibrosisfwCFCF-pregnancyCF-pregnancies
…duction Since widespread availability of highly effective CFTRm elexacaftor/tezacaftor/ivacaftor, pregancy rates have doubled among fwCF in…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 256 of 876A13IPFIPF-derived
…nt displayed a reduced capacity to generate intracellular cAMP. A13 treatment reversed the pro-adhesive phenotype and significantly…
mepolizumabT2 high SAGSKT2 high severe asthmaNCT05144087
…llected by bronchoscopy at baseline (T0) and 6 months (T6) post mepolizumab treatment ( NCT05144087, GSK funded, investigator led study). F…
cannabisPubMedmyocardial infarctionMACEWeb of ScienceScopusstrokeACS
… the potential associated risks to the cardiovascular health of cannabis users. The objective was to evaluate the possible association b…
tofacitinibSkindex-29SLEpelvic inflammatory disease
…the pharmacokinetics, effectiveness, safety and tolerability of tofacitinib in young adults with active mucocutaneous (MC) SLE manifestatio…
prednisonecolchicinePeking Union Medical CollegeChinese Academy of Medical SciencesRecurrent in-stent restenosisRISRFuwai Hospitalstandard medical therapy
…e 0.5 mg/kg/day, tapered monthly to 5–10 mg/day over 12 months (prednisone group). All groups receive background standard therapy per guid…
bDMARDsBiological disease-modifying antirheumatic drugsrheumatic diseaseseHealth interventions
…Objectives Biological disease-modifying antirheumatic drugs (bDMARDs) require specific storage temperatures, but are frequently stor…
Prochlorperazinenausea and vomiting
…Prochlorperazine is a commonly used medicine to treat nausea and vomiting. The o…
OCSEFGefgartigimodmyasthenia gravis
…y dataset.Results 169 adults (≥18 years) who were using chronic OCS pre-EFG initiation, initiated EFG by December 31, 2022, and con…
OnabotAcervical dystoniaUTIchronic migrainemigraineneck pain
…. No patients were determined to have lack of effect.Conclusion OnabotA demonstrated consistent safety with no new signals observed in …
TolebrutinibocrelizumabPPMSsecondary progressive MSprimary progressive MSPERSEUSNCT04458051
…Background Tolebrutinib, an oral, brain-penetrant, bioactive Bruton’s tyrosine kinase i…
EdaravoneALSPharmaceutical Benefits SchemeTGA Special Access SchemePBSTGATherapeutic Goods AdministrationHASO
… alleviates the stress of travelling to hospital for treatment. Edaravone infusions at home are safe.…